Celltrion partners with US pharmacy chain for Yuflyma sales

发布时间：2023-12-05 20:13:52 作者：玩站小弟

Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US s 。

Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.

CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.

Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.

Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.

Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.

Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.

“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.

Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.

PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.

Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.

Tag： %E8%99%8E%E7%89%99%E5%A6%B9%E5%AD%90%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E8%A7%A3%E8%AF%B4%E9%95%9C%E5%A4%B4%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%99%8E%E7%89%99%E5%A6%B9%E5%AD%90%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E8%A7%A3%E8%AF%B4%E9%95%9C%E5%A4%B4%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%99%8E%E7%89%99%E5%A6%B9%E5%AD%90%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E8%A7%A3%E8%AF%B4%E9%95%9C%E5%A4%B4app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%99%8E%E7%89%99%E5%A6%B9%E5%AD%90%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E8%A7%A3%E8%AF%B4%E9%95%9C%E5%A4%B4%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E7%AB%9E%E5%BD%A9%E7%AF%AE%E7%90%83%E5%BC%80%E5%A5%96%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E7%AB%9E%E5%BD%A9%E7%AF%AE%E7%90%83%E5%BC%80%E5%A5%96%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E7%AB%9E%E5%BD%A9%E7%AF%AE%E7%90%83%E5%BC%80%E5%A5%96%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E7%AB%9E%E5%BD%A9%E7%AF%AE%E7%90%83%E5%BC%80%E5%A5%96%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E4%B8%AD%E5%9B%BD%E7%AF%AE%E7%90%83%E4%BB%8A%E6%97%A5%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E4%B8%AD%E5%9B%BD%E7%AF%AE%E7%90%83%E4%BB%8A%E6%97%A5%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E4%B8%AD%E5%9B%BD%E7%AF%AE%E7%90%83%E4%BB%8A%E6%97%A5%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E4%B8%AD%E5%9B%BD%E7%AF%AE%E7%90%83%E4%BB%8A%E6%97%A5%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E4%BF%84%E7%BD%97%E6%96%AF%E6%B2%99%E7%89%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E9%A2%91%E9%81%93%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E4%BF%84%E7%BD%97%E6%96%AF%E6%B2%99%E7%89%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E9%A2%91%E9%81%93%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E4%BF%84%E7%BD%97%E6%96%AF%E6%B2%99%E7%89%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E9%A2%91%E9%81%93app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E4%BF%84%E7%BD%97%E6%96%AF%E6%B2%99%E7%89%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E9%A2%91%E9%81%93%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E7%AF%AE%E7%90%83%E7%9B%B4%E6%92%AD%E5%AD%A3%E5%89%8D%E8%B5%9B%E4%BA%8B%E7%AD%96%E5%88%92%E6%96%B9%E6%A1%88%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E7%AF%AE%E7%90%83%E7%9B%B4%E6%92%AD%E5%AD%A3%E5%89%8D%E8%B5%9B%E4%BA%8B%E7%AD%96%E5%88%92%E6%96%B9%E6%A1%88%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E7%AF%AE%E7%90%83%E7%9B%B4%E6%92%AD%E5%AD%A3%E5%89%8D%E8%B5%9B%E4%BA%8B%E7%AD%96%E5%88%92%E6%96%B9%E6%A1%88app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E7%AF%AE%E7%90%83%E7%9B%B4%E6%92%AD%E5%AD%A3%E5%89%8D%E8%B5%9B%E4%BA%8B%E7%AD%96%E5%88%92%E6%96%B9%E6%A1%88%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E8%B6%B3%E7%90%83%E6%9C%80%E5%BC%BA%E9%98%B5%E5%AE%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E8%B6%B3%E7%90%83%E6%9C%80%E5%BC%BA%E9%98%B5%E5%AE%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E6%9C%80%E5%BC%BA%E9%98%B5%E5%AE%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0app%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E8%B6%B3%E7%90%83%E6%9C%80%E5%BC%BA%E9%98%B5%E5%AE%B9%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E5%B9%B3%E5%8F%B0%20-%E3%80%8B 2017%E6%96%AF%E8%AF%BA%E5%85%8B%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F2017%E6%96%AF%E8%AF%BA%E5%85%8B%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F2017%E6%96%AF%E8%AF%BA%E5%85%8B%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F2017%E6%96%AF%E8%AF%BA%E5%85%8B%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E4%B8%AD%E8%B6%85%E8%81%94%E8%B5%9B%E8%B5%9B%E4%BA%8B%E5%9C%A8%E5%93%AA%E9%87%8C%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E4%B8%AD%E8%B6%85%E8%81%94%E8%B5%9B%E8%B5%9B%E4%BA%8B%E5%9C%A8%E5%93%AA%E9%87%8C%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E4%B8%AD%E8%B6%85%E8%81%94%E8%B5%9B%E8%B5%9B%E4%BA%8B%E5%9C%A8%E5%93%AA%E9%87%8C%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E4%B8%AD%E8%B6%85%E8%81%94%E8%B5%9B%E8%B5%9B%E4%BA%8B%E5%9C%A8%E5%93%AA%E9%87%8C%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B %E5%A5%A5%E8%BF%90%E6%8E%92%E7%90%83%E5%87%A0%E7%82%B9%E7%BB%93%E6%9D%9F%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E2%98%80%EF%B8%8F%E5%AE%98%E7%BD%91%206004.net%E2%9C%94%EF%B8%8F%E3%8A%99%EF%B8%8F%EF%B8%8F%E5%A5%A5%E8%BF%90%E6%8E%92%E7%90%83%E5%87%A0%E7%82%B9%E7%BB%93%E6%9D%9F%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%E2%98%80%EF%B8%8F%E5%A5%A5%E8%BF%90%E6%8E%92%E7%90%83%E5%87%A0%E7%82%B9%E7%BB%93%E6%9D%9F%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%ADapp%E4%B8%8B%E8%BD%BD%E2%98%80%EF%B8%8F%E5%A5%A5%E8%BF%90%E6%8E%92%E7%90%83%E5%87%A0%E7%82%B9%E7%BB%93%E6%9D%9F%E8%B5%9B%E4%BA%8B%E7%9B%B4%E6%92%AD%E5%B9%B3%E5%8F%B0%20-%E3%80%8B

김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
김성원 국민의힘 의원이 지난 6월 19일 오전 서울 여의도 국회 의원회관에서 열린 제3회 UCAI 포럼 세미나 : 금융 범죄 예방과 경쟁력 강화를 위한 한·미 AI 협력 세미나에서
2023-12-05
XG storms back with 'New DNA'
Japanese K-pop band XG returned to the music scene on Wednesday with its first EP "New DNA."The late
2023-12-05
Revamped Genesis GV80 and first coupe sibling unveiled
Hyundai Motor Group on Tuesday unveiled the updates to its high-end brand Genesis’ sport utility veh
2023-12-05
[Herald Interview] Forever is not impossible: Oneus aspires to global reach with 'La Dolce Vita'
Every Oneus album is a well-made package of music, story, artistry and performance. With its latest
2023-12-05
Yoon lauds rapid growth of Korean defense industry
President Yoon Suk Yeol on Tuesday pledged to boost the global competitiveness of South Korea's
2023-12-05
S. Korean fencer Oh Sang
HANGZHOU, China --South Korean fencer Oh Sang-uk claimed the gold medal in the men's individual sabr
2023-12-05